Jiri Keirsse and Toshal Patel from UCB explore how open innovation programmes support collaboration between academia and industry. The session highlights the role of KTOs, industry expectations, and…
The Equity, Diversity and Inclusion (EDI) Calendar 2026 – Vertical Mobile Version, developed by the EDI Special Interest Group (SIG), highlights key global EDI awareness days, weeks and months together with important Knowledge Transfer (KT) dates in a mobile-optimised layout. Designed for…
The Equity, Diversity and Inclusion Calendar 2026 (horizontal version), created by the EDI SIG, combines key international EDI awareness days, weeks and months with important Knowledge Transfer dates in a clear, at-a-glance format. Designed for desktop use, presentations and printing, the…
Shona D’Arcy presents EIT Health’s role in bridging the research-to-market gap. She explores the evolving journey of university spin-outs, compares academic and bootstrapped start-ups, and…
Peter Nussbaumer and Gernot Faustmann presented the KHAN/LDC initiative—a collaborative drug discovery platform supporting European academics. Without requiring spin-out formation, it helps mature…
Discover how Europe’s public research organisations are driving innovation. Explore the EPO’s latest study and learn how stronger knowledge transfer and new tools like the Deep Tech Finder are shaping Europe’s future.
Ankita Das explores how the venture builder model helps transform academic biotech research into market-ready solutions. She examines why the funding gap persists, how to de-risk IP, and offers…
Europe produces outstanding fundamental research but struggles to translate it into impact. Many patented inventions remain unexploited, and start-ups abroad often capture more benefit than European entities. This ASTP webinar series explores practical tools and models that help research projects…
Nadina Grosios outlines the regulatory path from academic drug discovery to market, highlighting key studies and concepts that support clinical trial submissions, funding access, and partnership…
Philippe Tschopp explores how aligning manufacturing design with regulatory and clinical strategy enhances the development of oral solid drug products. He focuses on GMP, GLP, and TPP as key…
Thomas Hanke shares his perspective on how to strategically plan and execute preclinical validation for translational academic research. Drawing on his experience at Evotec—a leading biotechnology…
A new study from the European Patent Office (EPO) explores how innovation ecosystems are shaping the future of oncology, with knowledge transfer playing a crucial role in bridging the gap between research and market-ready solutions. New Frontiers in Oncology: An Evolving Innovation Ecosystem…
Join our newsletter and get the latest news
We process your data in accordance with GDPR and our Privacy Policy.
